Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: Seronegative antiphospholipid syndrome?

Lupus

Volumn 19, Issue 11, 2010, Pages 1340-1343

  Sopeña, Bernardo ^a,b   Perez Rodriguez M T ^a   Rivera, A ^a   Ortiz Rey, J A ^a   Lamas, J ^a   Freire Dapena, M C ^a  

^a UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

livedoid vasculopathy; seronegative antiphospholipid syndrome; systemic lupus erythematosus

Indexed keywords

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CAUCASIAN; DIFFERENTIAL DIAGNOSIS; FEMALE; HEMOLYTIC ANEMIA; HUMAN; HUMAN TISSUE; LIVEDO RETICULARIS; PRIORITY JOURNAL; SKIN BLOOD VESSEL DISORDER; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; VEIN THROMBOSIS;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; LIVEDO RETICULARIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RECURRENCE; THROMBOSIS;

EID: 78649721317     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310373783     Document Type: Article

References (26)

1. Hughes GR, Khamashta MA Seronegative antiphospholipid syndrome. Ann Rheum Dis 2003 ; 62: 1127.
2. Jawad AS Seronegative antiphospholipid syndrome. Ann Rheum Dis 2004 ; 63: 608.
3. Ruiz-Irastorza G., Khamashta MA, Hughes GR Hughes syndrome crosses boundaries. Autoimmun Rev 2002 ; 1: 43-48.
4. Miyakis S., Lockshin MD, Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 ; 4: 295-306.
5. Bobba RS, Johnson SR, Davis AM A review of the Sapporo and revised Sapporo criteria for the classification of antiphospholipid syndrome Where do the revised Sapporo criteria add value? J Rheumatol 2007 ; 34: 1522-1527.
6. Kaul M., Erkan D., Sammaritano L., Lockshin MD Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Ann Rheum Dis 2007 ; 66: 927-930.
7. Asherson RA The primary, secondary, catastrophic, and seronegative variants of the antiphospholipid syndrome: a personal history long in the making. Semin Thromb Hemost 2008 ; 34: 227-235.
8. Mialdea M., Sangle SR, D'Cruz DP Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis. J Autoimmune Dis 2009 ; 6: 3.
9. Alessandri C., Conti F., Conigliaro P., Mancini R., Massaro L., Valesini G. Seronegative autoimmune diseases. Ann NY Acad Sci 2009 ; 1173: 52-59.
10. Sangle S., D'Cruz DP, Hughes GR Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies. Ann Rheum Dis 2005 ; 64: 147-148.
11. Jorizzo JL Livedoid vasculopathy: what is it? Arch Dermatol 1998 ; 134: 491-493.
12. Acland KM, Darvay A., Wakelin SH, Russell-Jones R. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol 1999 ; 140: 131-135.
13. Hairston BR, Davis MD, Pittelkow MR, Ahmed I. Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 2006 ; 142: 1413-1418.
14. Francès C., Niang S., Laffitte E., Pelletier F., Costedoat N., Piette JC Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum 2005 ; 52: 1785-1793.
15. Cervera R., Piette JC, Font J., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002 ; 46: 1019-1027. (Pubitemid 34303815)
16. Callen JP Livedoid vasculopathy: what it is and how the patient should be evaluated and treated. Arch Dermatol 2006 ; 142: 1481-1482.
17. Khenifer S., Thomas L., Balme B., Dalle S. Livedoid vasculopathy: thrombotic or inflammatory disease? Clin Exp Dermatol 2009 ; (in press).
18. Carlson JA, Chen KR Cutaneous pseudovasculitis. Am J Dermatopathol 2007 ; 29: 44-55.
19. Frances C., Barete S. Difficult management of livedoid vasculopathy. Arch Dermatol 2004 ; 140: 1011.
20. Weinstein S., Piette W. Cutaneous manifestations of antiphospholipid antibody syndrome. Hematol Oncol Clin North Am 2008 ; 22: 67-77.
21. Jeffries M., Hamadeh F., Aberle T., et al. Haemolytic anaemia in a multi-ethnic cohort of lupus patients: a clinical and serological perspective. Lupus 2008 ; 17: 739-743.
22. Giannouli S., Voulgarelis M., Ziakas PD, Tzioufas AG Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment. Ann Rheum Dis 2006 ; 65: 144-148.
23. Fernandez M., Alarcon GS, Apte M., Andrade RM, Vila LM, Reveille JD Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factor. Arthritis Rheum 2007 ; 56: 614-621.
24. Ziakas PD, Giannouli S., Zintzaras E., Tzioufas AG, Voulgarelis M. Lupus thrombocytopenia: clinical implications and prognostic significance. Ann Rheum Dis 2005 ; 64: 1366-1369.
25. Danowski A., de Azevedo MN, de Souza, Papi JA, Petri M. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J Rheumatol 2009 ; 36: 1195-1199.
26. Somers E., Magder LS, Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 2002 ; 29: 2531-2536. (Pubitemid 35416957)